• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE - HAYWARD FLOSEAL HEMOSTATIC MATRIX; AGENT, ABSORBABLE HEMOSTATIC, COLLAGEN BASED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE - HAYWARD FLOSEAL HEMOSTATIC MATRIX; AGENT, ABSORBABLE HEMOSTATIC, COLLAGEN BASED Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problem No Code Available (3191)
Event Type  Injury  
Event Description
Patient 2 of 3: from literature: cenk gurbuz, et.Al."off-clamp laparoscopic partial nephrectomy for a low renal nephromethry scored patients".A-18.Introduction and objectives: because of the impact warm ischemia time may have on renal function, various surgical techniques have been proposed to minimize or eliminate warm ischemia.The objective of this study is to evaluate our initial outcomes of trans or retroperitoneal partial nephrectomy (r/tlpn) performed by off-clamp excision.Methods: between august 2012 and march 2014, 41 consecutive patients underwent off clamp r/tlpn at our institution.After excision of tumor, renorrhaphy plus biologic hemostatics flosealô (baxter healthcare corp., (b)(4)) were performed.Results: majority of the patients (39) were noted to have a low (4¿6) renal nephromethry score (rns) and 2 patients had a moderate (7¿9) rns.No hilar location tumor was noted.The mean tumor size among this cohort was 33.1 (range, 2.0¿6.0) cm, and the mean estimated blood loss was 266 (range, 70¿500)ml.One patient required blood transfusion.Open conversion was needed in 1 patient.The mean hospital stay was 2.9 (range, 2¿5) days.The mean percentage of postoperative estimated glomerular filtration rate change increased by 0.8%.Two patients with grade iii complication by the clavien-dindo classification were treated by endoscopic intervention.Surgical margin was noted positive in 3 patients.Conclusions: our initial experience with off-clamp lpn demonstrates encouraging results of minimal renal function loss and complications in patients with a low rns.Two (2) patients grade iii clavien complications.One (1) patient required conversion to open surgery.(this complaint is regarding one of two patients with grade iii clavien complications.) note: the occurrence date is unknown.
 
Manufacturer Narrative
(b)(4).Due to the lack of information, this case is currently not assessable and is being conservatively reported.Baxter is currently in the process of following up with the reporter for additional information.A follow-up report will be submitted upon receipt and evaluation of additional information.
 
Manufacturer Narrative
(b)(4).Multiple attempts were made to contact the author to retrieve additional clinical details.No response was received.Baxter hayward completed the investigation.As neither the lot number nor sample were provided, no batch review or sample evaluation was possible.A review of details of the complaint indicated that no further investigation is required.No trend was identified.If additional information is received at a later time, the information will be evaluated and a follow-up submission will be sent.This case will be kept on file for trending purposes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLOSEAL HEMOSTATIC MATRIX
Type of Device
AGENT, ABSORBABLE HEMOSTATIC, COLLAGEN BASED
Manufacturer (Section D)
BAXTER HEALTHCARE - HAYWARD
2024 w winton ave
hayward CA 94545
Manufacturer (Section G)
BAXTER HEALTHCARE - HAYWARD
2024 w winton ave
hayward CA 94545
Manufacturer Contact
kimberly crane
one baxter way
westlake village, CA 91362
8053723182
MDR Report Key4116096
MDR Text Key4841146
Report Number2032282-2014-00131
Device Sequence Number1
Product Code LMF
Combination Product (y/n)N
Reporter Country CodeTU
PMA/PMN Number
P990009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 09/16/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/24/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received10/23/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-